Identification of FMRP target mRNAs in the developmental brain: FMRP might coordinate Ras/MAPK, Wnt/β-catenin, and mTOR signaling during corticogenesis.


Journal

Molecular brain
ISSN: 1756-6606
Titre abrégé: Mol Brain
Pays: England
ID NLM: 101468876

Informations de publication

Date de publication:
16 12 2020
Historique:
received: 30 09 2020
accepted: 23 11 2020
entrez: 16 12 2020
pubmed: 17 12 2020
medline: 4 9 2021
Statut: epublish

Résumé

Corticogenesis is one of the most critical and complicated processes during embryonic brain development. Any slight impairment in corticogenesis could cause neurodevelopmental disorders such as Fragile X syndrome (FXS), of which symptoms contain intellectual disability (ID) and autism spectrum disorder (ASD). Fragile X mental retardation protein (FMRP), an RNA-binding protein responsible for FXS, shows strong expression in neural stem/precursor cells (NPCs) during corticogenesis, although its function during brain development remains largely unknown. In this study, we attempted to identify the FMRP target mRNAs in the cortical primordium using RNA immunoprecipitation sequencing analysis in the mouse embryonic brain. We identified 865 candidate genes as targets of FMRP involving 126 and 118 genes overlapped with ID and ASD-associated genes, respectively. These overlapped genes were enriched with those related to chromatin/chromosome organization and histone modifications, suggesting the involvement of FMRP in epigenetic regulation. We further identified a common set of 17 FMRP "core" target genes involved in neurogenesis/FXS/ID/ASD, containing factors associated with Ras/mitogen-activated protein kinase, Wnt/β-catenin, and mammalian target of rapamycin (mTOR) pathways. We indeed showed overactivation of mTOR signaling via an increase in mTOR phosphorylation in the Fmr1 knockout (Fmr1 KO) neocortex. Our results provide further insight into the critical roles of FMRP in the developing brain, where dysfunction of FMRP may influence the regulation of its mRNA targets affecting signaling pathways and epigenetic modifications.

Identifiants

pubmed: 33323119
doi: 10.1186/s13041-020-00706-1
pii: 10.1186/s13041-020-00706-1
pmc: PMC7739466
doi:

Substances chimiques

RNA, Messenger 0
Fragile X Mental Retardation Protein 139135-51-6
TOR Serine-Threonine Kinases EC 2.7.11.1
Mitogen-Activated Protein Kinases EC 2.7.11.24
ras Proteins EC 3.6.5.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

167

Références

Mol Cell Biol. 2013 Jul;33(13):2551-9
pubmed: 23629626
J Neurosci. 2003 Jul 2;23(13):5919-27
pubmed: 12843296
Dev Cell. 2008 Jun;14(6):926-39
pubmed: 18539120
Nucleic Acids Res. 2019 Jan 8;47(D1):D1038-D1043
pubmed: 30445645
Nat Neurosci. 2013 Nov;16(11):1537-43
pubmed: 24165680
Nat Neurosci. 2013 Nov;16(11):1530-6
pubmed: 23584741
Proc Natl Acad Sci U S A. 2018 Nov 27;115(48):E11397-E11405
pubmed: 30373821
Sci Rep. 2017 Mar 24;7(1):391
pubmed: 28341829
Nat Neurosci. 2014 Dec;17(12):1693-700
pubmed: 25402856
Mol Brain. 2013 Apr 08;6:15
pubmed: 23566911
Dev Biol. 2001 Dec 1;240(1):237-46
pubmed: 11784059
Front Mol Neurosci. 2018 Mar 15;11:41
pubmed: 29599705
Nat Neurosci. 2003 Nov;6(11):1153-61
pubmed: 14528310
Neuron. 2003 Feb 6;37(3):417-31
pubmed: 12575950
Int J Mol Sci. 2018 May 22;19(5):
pubmed: 29789464
Front Neurosci. 2013 Oct 24;7:191
pubmed: 24167470
Cell. 2017 Sep 7;170(6):1209-1223.e20
pubmed: 28823556
J Neurosci. 2010 Jan 13;30(2):694-702
pubmed: 20071534
Genes Brain Behav. 2012 Apr;11(3):332-41
pubmed: 22268788
BMC Med Genet. 2015 Nov 05;16:102
pubmed: 26542245
J Biol Chem. 2009 Sep 18;284(38):25479-87
pubmed: 19640847
PLoS Genet. 2010 Apr 08;6(4):e1000898
pubmed: 20386739
Am J Med Genet A. 2008 Aug 15;146A(16):2060-9
pubmed: 18570292
Dev Dyn. 2020 Jun;249(6):698-710
pubmed: 32012381
J Neurosci. 2010 Dec 15;30(50):16910-21
pubmed: 21159962
Nat Neurosci. 2007 May;10(5):578-87
pubmed: 17417632
Neurogenetics. 2007 Apr;8(2):121-30
pubmed: 17216419
Brain Res Bull. 2016 Jul;125:79-91
pubmed: 27113433
EMBO Rep. 2018 Dec;19(12):
pubmed: 30361391
J Neurosci. 2008 Jan 9;28(2):543-7
pubmed: 18184796
Mol Brain. 2019 Jun 14;12(1):56
pubmed: 31200759
Trends Genet. 2017 Oct;33(10):703-714
pubmed: 28826631
Proc Natl Acad Sci U S A. 2015 Aug 25;112(34):E4697-706
pubmed: 26307763
Cell Rep. 2013 Oct 31;5(2):433-44
pubmed: 24139800
Cell Rep. 2015 May 5;11(5):727-36
pubmed: 25921541
Cell Death Differ. 2009 Jun;16(6):910-20
pubmed: 19282871
FEBS Lett. 2017 Dec;591(24):3978-3992
pubmed: 29194577
Mol Cell Biol. 2002 Dec;22(23):8332-41
pubmed: 12417734
Development. 2004 Jun;131(12):2791-801
pubmed: 15142975
Neuron. 2008 Oct 23;60(2):201-14
pubmed: 18957214
Front Mol Neurosci. 2018 Jan 12;10:440
pubmed: 29375303
Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17834-9
pubmed: 16314562
Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15996-6001
pubmed: 21896734
Stem Cells Dev. 2015 Oct 15;24(20):2353-65
pubmed: 26393806
Front Oncol. 2017 Jul 05;7:140
pubmed: 28725634
Nature. 2012 Dec 20;492(7429):382-6
pubmed: 23235829
J Neurosci. 2011 Jan 26;31(4):1427-39
pubmed: 21273427
Nucleic Acids Res. 2018 Jul 6;46(12):6344-6355
pubmed: 29668986
Nat Protoc. 2015 Jun;10(6):823-44
pubmed: 25950236
Science. 2018 Aug 17;361(6403):709-712
pubmed: 30115809
J Neurosci. 2020 Feb 5;40(6):1355-1365
pubmed: 31882402
Cell Stem Cell. 2007 Oct 11;1(4):443-57
pubmed: 18371380
Trends Genet. 2016 Mar;32(3):139-146
pubmed: 26830258
Mol Autism. 2013 Oct 03;4(1):36
pubmed: 24090431
Am J Hum Genet. 2014 Mar 6;94(3):470-8
pubmed: 24607389
Mol Psychiatry. 2020 Aug;25(8):1688-1703
pubmed: 31822816
Hum Genet. 2008 May;123(4):371-8
pubmed: 18322702
Neurosci Lett. 2009 Oct 25;462(3):267-71
pubmed: 19607881
Genes Cells. 2013 Aug;18(8):636-49
pubmed: 23679989
J Neurochem. 2018 Sep;146(5):500-525
pubmed: 29570795
Annu Rev Neurosci. 2018 Jul 8;41:1-23
pubmed: 29490194
Annu Rev Genomics Hum Genet. 2014;15:195-213
pubmed: 25184530
Nat Rev Genet. 2008 May;9(5):341-55
pubmed: 18414403
Nat Commun. 2018 Jun 27;9(1):2494
pubmed: 29950602
Eur J Hum Genet. 2008 Jun;16(6):666-72
pubmed: 18398441
Cell. 1994 Jul 15;78(1):23-33
pubmed: 8033209
Cell. 2001 Nov 16;107(4):477-87
pubmed: 11719188
Front Cell Neurosci. 2020 Jan 24;13:576
pubmed: 32038172
Genet Med. 2019 Apr;21(4):850-860
pubmed: 30245513
Cell. 2011 Jul 22;146(2):247-61
pubmed: 21784246
Cell Metab. 2019 Jan 8;29(1):192-201.e7
pubmed: 30197302
Curr Biol. 2016 Dec 19;26(24):3383-3392
pubmed: 27916527
Cell Reprogram. 2010 Jun;12(3):263-73
pubmed: 20698768
Nucleic Acids Res. 2018 Jan 4;46(D1):D836-D842
pubmed: 29092072
Elife. 2019 Dec 20;8:
pubmed: 31860442
Nat Med. 2011 Jun;17(6):726-31
pubmed: 21623382
Genes Dev. 2013 Nov 15;27(22):2473-88
pubmed: 24240237
J Neurosci Methods. 2013 Apr 15;214(2):170-6
pubmed: 23357027
Cell. 1991 May 31;65(5):905-14
pubmed: 1710175
Nucleic Acids Res. 2010 Jan;38(Database issue):D792-9
pubmed: 19906719

Auteurs

Cristine R Casingal (CR)

Department of Developmental Neuroscience, United Center for Advanced Research and Translational Medicine (ART), Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.

Takako Kikkawa (T)

Department of Developmental Neuroscience, United Center for Advanced Research and Translational Medicine (ART), Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.

Hitoshi Inada (H)

Department of Developmental Neuroscience, United Center for Advanced Research and Translational Medicine (ART), Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.
Laboratory of Health and Sports Sciences, Division of Biomedical Engineering for Health and Welfare, Tohoku University Graduate School of Biomedical Engineering, 6-6-12, Aramaki Aza Aoba Aoba-ku, Sendai, Miyagi, 980-8579, Japan.

Yukio Sasaki (Y)

Functional Structure Biology Laboratory, Department of Medical Life Science, Yokohama City University Graduate School of Medical Life Science, 1-7-29 Suehiro-cho, Tsumuri-ku, Yokohama, 230-0045, Japan.

Noriko Osumi (N)

Department of Developmental Neuroscience, United Center for Advanced Research and Translational Medicine (ART), Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan. osumi@med.tohoku.ac.jp.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH